Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 10-05-2023
The Revenue for the quarter ended  March 2023 of Rs. 45540.00 millions grew by 24.13 % from Rs. 36687.00 millions.The Profit  for the quarter ended March 2023 of  Rs. 6724.00  millions  grew by 60.21% from Rs. 4197.00 millions.OP of the company witnessed a marginal growth to 11759.00 millions from 7846.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 45540.00 36687.00 24.13 169625.00 144052.00 17.75 169625.00 144052.00 17.75
Other Income 1148.00 1147.00 0.09 5913.00 4820.00 22.68 5913.00 4820.00 22.68
PBIDT 11759.00 7846.00 49.87 48061.00 30761.00 56.24 48061.00 30761.00 56.24
Interest 26.00 127.00 -79.53 169.00 380.00 -55.53 169.00 380.00 -55.53
PBDT 11733.00 7719.00 52.00 47892.00 30381.00 57.64 47892.00 30381.00 57.64
Depreciation 2367.00 2052.00 15.35 9232.00 8143.00 13.37 9232.00 8143.00 13.37
PBT 9366.00 5667.00 65.27 38660.00 22238.00 73.85 38660.00 22238.00 73.85
TAX 2642.00 1470.00 79.73 12532.00 6006.00 108.66 12532.00 6006.00 108.66
Deferred Tax 323.00 496.00 -34.88 3891.00 2080.00 87.07 3891.00 2080.00 87.07
PAT 6724.00 4197.00 60.21 26128.00 16232.00 60.97 26128.00 16232.00 60.97
Equity 833.00 832.00 0.12 833.00 832.00 0.12 833.00 832.00 0.12
PBIDTM(%) 25.82 21.39 20.74 28.33 21.35 32.69 28.33 21.35 32.69